SOLIGENIX, INC. Cash and Equivalents

Quick Answer

SOLIGENIX, INC. reported Cash and Equivalents of $26.04 million for fiscal year 2021.

SOLIGENIX, INC. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2021 $26.04M +39.4%
2020 $18.68M +244.5%
2019 $5.42M -39.7%
2018 $8.98M +15.0%
2017 $7.81M -11.0%
2016 $8.77M +78.2%
2015 $4.92M -10.9%
2014 $5.53M -5.7%
2013 $5.86M +74.5%
2012 $3.36M -44.0%
2011 $6.00M -19.5%
2010 $7.45M -3.1%
2009 $7.69M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
March 31, 2022 $22.88M -25.1% -12.2%
December 31, 2021 $26.04M +39.4% -9.8%
September 30, 2021 $28.87M +154.5% -0.4%
June 30, 2021 $28.98M +159.5% -5.1%
March 31, 2021 $30.54M +324.0% +63.5%
December 31, 2020 $18.68M +244.5% +64.7%
September 30, 2020 $11.34M +73.1% +1.6%
June 30, 2020 $11.17M +59.9% +55.0%
  • SOLIGENIX, INC. showed an increase of +39.4% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2009–2021 period, SOLIGENIX, INC.’s cash and equivalents has grown by 238.6% (from $7.69 million to $26.04 million).
  • The most recent figure is from SOLIGENIX, INC.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 29, 2022.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment